Michelle LaSpaluto
Director of Finance/CFO at CHIMERIX, INC.
Net worth: 98 900 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Sherman | M | 58 | 5 years | |
Michael Andriole | M | 51 | 5 years | |
Martha Demski | F | 71 | 19 years | |
Clarence Machado | M | 60 | 10 years | |
Roy W. Ware | M | - | 17 years | |
David Jakeman | M | 47 | 15 years | |
Victoria Vakiener | F | 60 | 3 years | |
Lisa Decker | M | 55 | 1 years | |
Robert Meyer | M | 65 | 6 years | |
Fred Middleton | M | 74 | 6 years | |
Pratik Multani | M | 57 | 4 years | |
Michael Alrutz | M | 54 | 12 years | |
Joshua Allen | M | - | 3 years | |
Odin Naderer | M | - | 10 years | |
Thomas Riga | M | 48 | 1 years | |
Allen Melemed | M | 60 | 4 years | |
Caryn Barnett | F | - | 4 years | |
Christopher L. Jordan | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
George R. Painter | M | - | 12 years | |
Timothy J. Wollaeger | M | 80 | 16 years | |
Kenneth Moch | M | 69 | 5 years | |
James Niedel | M | 79 | 7 years | |
M. Berrey | M | 57 | 7 years | |
Ronald Renaud | M | 55 | 6 years | |
Catherine Lynch Gilliss | M | 75 | 9 years | |
Edward F. Greissing | M | 73 | 3 years | |
James Daly | M | 63 | 6 years | |
John Leonard | M | 66 | 4 years | |
Timothy Trost | M | 66 | 7 years | |
Wende Hutton | F | 63 | - | |
Joseph T. Schepers | M | 65 | 3 years | |
Art Pappas | M | 76 | 3 years | |
Ernest Mario | M | 85 | - | |
Lisa Ricciardi | F | 64 | - | |
Peter N. Payne | M | 64 | 2 years | |
Randall Lanier | M | - | 16 years | |
Joseph F. Rutledge | M | - | - | |
Kevin Reeves | M | - | - | |
Andrew Barrett | M | - | 1 years | |
Michelle L. Rose | M | - | 8 years | |
Heather Knight | M | - | - | |
Roberto Guzman | M | - | - | |
Thomas A. Pitler | M | 65 | - | |
Essy Mozaffari | M | - | - | |
Linda M. Richardson | F | 60 | 5 years | |
Jung Choi | F | 54 | 2 years | |
Peter Young | M | 74 |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | 7 years |
Rodman L. Drake | M | 80 | 1 years | |
Farah Champsi | F | 62 | 4 years | |
William Nichols | M | 55 | 6 years | |
Michael D. Rogers | M | 68 | 3 years | |
Lauren Hartle | M | - |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 52 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michelle LaSpaluto
- Personal Network